Arvunescu, A.M.; Ionescu, R.F.; Dumitrescu, S.I.; Zaharia, O.; Nanea, T.I.
Guideline-Optimised Treatment in Heart Failure—Do Higher Doses Reduce Systemic Inflammation More Significantly? J. Clin. Med. 2024, 13, 3056.
https://doi.org/10.3390/jcm13113056
AMA Style
Arvunescu AM, Ionescu RF, Dumitrescu SI, Zaharia O, Nanea TI.
Guideline-Optimised Treatment in Heart Failure—Do Higher Doses Reduce Systemic Inflammation More Significantly? Journal of Clinical Medicine. 2024; 13(11):3056.
https://doi.org/10.3390/jcm13113056
Chicago/Turabian Style
Arvunescu, Alexandru Mircea, Ruxandra Florentina Ionescu, Silviu Ionel Dumitrescu, Ondin Zaharia, and Tiberiu Ioan Nanea.
2024. "Guideline-Optimised Treatment in Heart Failure—Do Higher Doses Reduce Systemic Inflammation More Significantly?" Journal of Clinical Medicine 13, no. 11: 3056.
https://doi.org/10.3390/jcm13113056
APA Style
Arvunescu, A. M., Ionescu, R. F., Dumitrescu, S. I., Zaharia, O., & Nanea, T. I.
(2024). Guideline-Optimised Treatment in Heart Failure—Do Higher Doses Reduce Systemic Inflammation More Significantly? Journal of Clinical Medicine, 13(11), 3056.
https://doi.org/10.3390/jcm13113056